OncoDaily
LightNews LightNews
banner
oncodaily.bsky.social
OncoDaily
@oncodaily.bsky.social
3.4K followers 7.8K following 3.1K posts
Your daily dose of hope, inspiration, and information in the fight against cancer.
oncodaily.com
Posts Replies Media Videos
oncodaily.bsky.social
ASCO - Reminder to Nominate for the Women Who Conquer Cancer Mentorship Award

@ascocancer.bsky.social @conquercancer.bsky.social

oncodaily.com/voices/women...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 24, 2025 at 12:06 AM
oncodaily.bsky.social
FDA Immunotherapy Approvals: First Half of 2025

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #FDA #FDAApproval #IO #Immunotherapy
November 17, 2025 at 11:00 PM
oncodaily.bsky.social
FGD3 as a Critical Modulator of Chemotherapy and Immunotherapy Response in Breast Cancer

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 16, 2025 at 6:20 PM
oncodaily.bsky.social
UICC World Cancer Leaders’ Summit 2025: Bridging Divides, Building Futures

@uiccofficial.bsky.social

oncodaily.com/voices/uicc-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 16, 2025 at 6:19 PM
oncodaily.bsky.social
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Daratumumab #MM #Myeloma
November 9, 2025 at 9:10 PM
oncodaily.bsky.social
SWOG S1605: UroAmp utDNA Predicts Immunotherapy Response in Bladder Cancer

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 7, 2025 at 9:46 PM
oncodaily.bsky.social
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

oncodaily.com/community/10...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 7, 2025 at 9:45 PM
oncodaily.bsky.social
SRT and Immunotherapy in Asymptomatic Brain Metastatic NSCLC

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SRT #Immunotherapy #NSCLC
November 4, 2025 at 8:37 PM
oncodaily.bsky.social
Evolution Trial Evaluates Radiotherapy-Free Chemoimmunotherapy with Pembrolizumab in Locally Advanced NSCLC with High PD-L1 Expression

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Evolution #Chemoimmunotherapy #Pembrolizumab #NSCLC
November 3, 2025 at 1:49 PM
oncodaily.bsky.social
LEAP-012: Pembrolizumab Plus Lenvatinib with Transarterial Chemoembolization in Unresectable, Non-Metastatic HCC

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LEAP-012 #HCC
November 2, 2025 at 9:41 PM
oncodaily.bsky.social
Immunotherapy Improves Survival in MSI-H Colon Cancer with Isolated Peritoneal Metastases

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ColonCancer
November 2, 2025 at 9:38 PM
oncodaily.bsky.social
LITESPARK-011: Dual HIF-2α and VEGF Pathway Blockade Demonstrates Superiority Over Cabozantinib Following PD-1/L1 Therapy in Advanced Renal Cell Carcinoma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #RCC #RenalCellCarcinoma #LITESPARK-011
October 31, 2025 at 1:36 PM
oncodaily.bsky.social
Predictive Modeling for Immunotherapy Response in Cancer: From Biomarkers to AI Integration

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Immunotherapy #IO
October 29, 2025 at 9:37 PM
oncodaily.bsky.social
Gevorg Tamamyan Recognized as Fellow of the American Society of Clinical Oncology (FASCO)

@ascocancer.bsky.social

oncodaily.com/voices/gevor...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ASCO #FASCO
October 29, 2025 at 9:36 PM
oncodaily.bsky.social
mRNA COVID-19 Vaccines Reprogram Tumor Immunity and Enhance Response to Checkpoint Inhibitors

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #COVID-19 #mRNAVaccine
October 28, 2025 at 8:49 PM
oncodaily.bsky.social
FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #FDA #Melanoma
October 26, 2025 at 9:14 PM
oncodaily.bsky.social
FDA Grants Breakthrough Therapy Designation to Zenocutuzumab-zbco for NRG1-Positive Cholangiocarcinoma

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Cholangiocarcinoma
October 24, 2025 at 8:50 PM
oncodaily.bsky.social
Dual Immune Checkpoint Blockade Targeting TIGIT and PD-1 Improves Outcomes in Advanced Gastroesophageal Adenocarcinoma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GastroesophagealAdenocarcinoma #GIOnc
October 15, 2025 at 12:11 AM
oncodaily.bsky.social
PIVOTAL Trial Shows Daromun Improves Recurrence-Free Survival in Stage III Melanoma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Melanoma #PIVOTAL
October 9, 2025 at 7:08 AM
oncodaily.bsky.social
Biomarkers and Dual Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Survival

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #NSCLC #LungCancer
October 5, 2025 at 6:54 PM
oncodaily.bsky.social
FDA Approves Lurbinectedin Plus Atezolizumab for Maintenance in Extensive-Stage Small Cell Lung Cancer

oncodaily.com/fda-approval...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
October 3, 2025 at 8:02 PM
oncodaily.bsky.social
Overcoming Antigen Escape With Fas FasL Bystander Killing in CAR-T Therapy

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
October 1, 2025 at 8:38 PM
oncodaily.bsky.social
In Vivo Genome-Wide CRISPR Screens in Human T Cells to Enhance T Cell Therapy for Solid Tumors

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SolidTumors #CRISPR
September 30, 2025 at 10:01 PM
oncodaily.bsky.social
OncoDaily LA is here!

We’re proud to launch OncoDaily LA, a new regional hub of OncoDaily, where oncology meets culture, community, and creative advocacy.

oncodaily.com/voices/oncod...

#OncoDailyLA #CancerMedia #OncologyCalifornia #YouthOutreach #PalliativeCare #LosAngeles #OncoDaily #OncoDailyTV
September 24, 2025 at 12:28 PM
oncodaily.bsky.social
Burnout Affects Over 50% of Palliative Care Clinicians and the Problem is not the Patients - Eduardo Bruera

@brueraeduardo.bsky.social

oncodaily.com/voices/372493

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PalliativeCare
September 18, 2025 at 12:37 PM